| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Driving microglia metabolism towards remyelination and restoration of brain damage in multiple sclerosis
|
|
Closed | 2016 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Il colon come produttore di ormoni: differenza di genere in condizioni fisiologiche e post-gonadectomia
|
|
Closed | 2020 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
An integrative approach for the systematic characterization of mitochondrial regulators in hepatocellular carcinoma (2° anno)
|
|
Closed | 2021 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Gender and affective disorders: role of vasopressin and neuroactive steroids
|
|
Closed | 2009 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
New strategies to enhance the trophic functions and remyelinating abilities of adult NG2-glia in amyotrophic lateral sclerosis via the GPR17 receptor (GPR17ALS-1)
|
|
Closed | 2020 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
An integrative approach for the systematic characterization of mitochondrial regulators in hepatocellular carcinoma (1° anno)
|
|
Closed | 2020 |
| CAR_EXT - CARIPLO - EXTRABANDO E PROGETTI TERRITORIALI |
From In silico to in vivo: an integrated computational and imaging pipeline to discriminate endocrine disrupters (EDs) vs endocrine modulators (EMs)
|
|
Closed | 2015 |
| CAR_RIC - Bandi Fondazione Cariplo |
Dissecting the role of anti-GluA3 antibodies in Frontotemporal Dementia: from bench to bedside
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
|
|
Ongoing | 2022 |
| CAR_RIC - Bandi Fondazione Cariplo |
Molecular mechanisms of NLRP3-inflammasome inhibition by Leishmania infantum-derived factors in the neuropathogenesis of Alzheimer's disease
|
|
Ongoing | 2023 |
